Your practice can help cats get back where they belong
Control Feline Osteoarthritis Pain
Solensia is the feline OA pain control therapy designed with the practice, the client, and the cat in mind.
OA IN CATS
The Prevalence of Feline Osteoarthritis
Feline OA is highly prevalent, but it can be difficult to diagnose cats when they don’t visit.
Nearly 40% of all cats have clinical signs of OA1
% Feline Patient Visits by Age2
60% of cats >6 years of age are affected by OA3
90% of cats >12 years of age are affected by OA4
Learning about OA pain motivates pet owners to see their veterinarian
Use the Cat OA Pain Checklist to start a discussion and help clients identify possible signs in their cat.
>50%
of cat owners who recognized OA pain signs in their cat were motivated to make an appointment with their veterinarian6
Interactive Checklist: Share this easy-to-use online tool with pet owners before their appointment.
Printable Checklist: You can also have copies of the checklist printed and ready for use in your waiting room or clinic exam rooms.
Watch and share this video with cat owners to show what these everyday behaviors look like in healthy cats compared with cats in pain. This can help them recognize and understand what their pet may be going through.
MULTIMODAL THERAPY
Analgesia is Foundational to a Multimodal OA Treatment Approach
Pain is the primary experience and treatable sign of OA
It is a multidimensional & uniquely individual experience
Pain becomes its own disease state when left untreated
Goals for Managing Feline OA
- Controlling pain
- Maintaining mobility
- Slowing the progression of the disease
But multimodal treatment can come with an unintended cost: Caregiver aversion
TREATMENT FOR OA
Treat Cats Monthly With Solensia
Providing early, effective treatment designed for long-term OA pain management is the goal. Solensia helps keep OA pain from disrupting the unique bond cats share with their humans.
How Solensia treats cats:
A monoclonal antibody that is metabolized the same as all proteins
Targets NGF, a key driver in OA pain progression
Administered in the veterinary clinic as a monthly injection
Insert text here...
View tips for examining cats for OA
Find additional resources for OA pain
Get an OA checklist for your clients
References
- Enomoto M, Mantyh PW, Murrell J, Innes JF, Lascelles BDX. Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats. Vet Rec. 2019;184(1):23.
- Zoetis Market Research: Feline Visit Growth Age MAT. September 2019.
- Slingerland L, Hazewinkel H, Meij B, Picavet P, Voorhout G. Cross-sectional study of the prevalence and clinical features of osteoarthritis in 100 cats. Vet J. 2011;187:304-309.
- Hardie EM, Roe SC, Martin FR. Radiographic evidence of degenerative joint disease in geriatric cats: 100 cases (1994–1997). J Am Vet Med Assoc. 2002;220:628-632.
- Lascelles BDX, Brown DC, Conzemius MG, Gill M, Oshinksy ML, Sharkey M. Measurement of chronic pain in companion animals: discussions from the Pain in Animals Workshop (PAW) 2017. Vet J. 2019;250(8):71-78.
- Data on File, November Pet Owner 2018 KG Marketsense, Zoetis Inc.
SLN-00004R4
IMPORTANT SAFETY INFORMATION:
See full Prescribing Information. For use in cats only. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid self-injection. Hypersensitivity reactions, including anaphylaxis, could potentially occur with self-injection. Solensia should not be used in breeding cats or in pregnant or lactating queens. Solensia should not be administered to cats with known hypersensitivity to frunevetmab. The most common adverse events reported in a clinical study were vomiting and injection site pain.